Research Project

Project Title:	A Phase II, randomised, open-label, multicentre study to assess the reactogenicity, safety and immunogenicity of GSK’s PED-HZ/su in paediatric renal transplant recipients (GSK , UK)
Project Type:	Clinical Trial, Enrolment ongoing Adjunct biobank: DNA, Serum, Plasma
Disease group(s):	Pediatric kidney transplantation
Project Summary:	A phase II, randomised, open-label, multicentre study to assess the reactogenicity, safety and immunogeni city of GSK’s paediatric Herpes Zoster subunit candidate vaccine (PED-HZ/su) when administered intramuscularly on a two-dose schedule to immunocompromised paediatric renal transplant recipients from 1 to 17 years of age.
Lead principal investigator(s):	Alberto Magnasco, Genoa
Co-investigator(s):	Francesca Lugani, Genoa
Project Period:	10/2019 - 10/2025
Sponsors:	Industry